Home/Pipeline/Fludeoxyglucose F‑18

Fludeoxyglucose F‑18

PET Imaging (Oncology)

CommercialApproved

Key Facts

Indication

PET Imaging (Oncology)

Phase

Commercial

Status

Approved

Company

Primo Biotechnology

About Primo Biotechnology

Taiwan‑based radiopharmaceutical innovator delivering precision cancer diagnostics and therapeutics.

View full company profile

Therapeutic Areas